12th February 2024
SMARTDYELIVERY AT THE APPLICANT DAY AT CARL-ZEISS-GYMNASIUM, JENA
On 9 February, the Bildungswerk der Thüringer Wirtschaft organised an "Applicant Day" at the mathematical, scientific and technical grammar school.
Interested pupils had one-on-one interviews with the companies taking part in this event in order to practise the special situation of a job interview.
SmartDyeLivery was happy to participate in this great way of promoting young talent and presented itself to the pupils.
1st February 2024
SMARTDYELIVERY CLOSES FINANCING ROUND IN THE MILLIONS AT THE BEGINNING OF THIS YEAR
After a successful 2023 and regulatory approval to conduct the Phase I clinical trial for its first platform-based product, SmartDyeLivery has once again reaffirmed the confidence of its investors. The investors continue to be fully confident in the company's development and are investing a multi-million Euro amount for the future development of SmartDyeLivery’s universal drug delivery platform.
17th November 2023
SMARTDYELIVERY INSPIRES YOUNG AND OLD AT THE SCIENCE EVENING AT JENA TALSCHULE
Surrounded by teddy bear surgery, a robot dog and laser shows, pupils and families from the Talschule in Jena were able to experiment with particle production at the SmartDyeLivery stall. Equipped with laboratory utensils, magnetic stirrers and alginate powder, interested children and adults tried their hand at being chemists and were able to take the results of their experiments home with them. With almost 1,000 visitors and 35 booths, the event was a great success and brought scientific phenomena closer to potential young researchers.
11th September 2023
SEPSIS UPDATE 2023: SMARTDYELIVERY BRINGS ITSELF UP TO DATE ON THE LATEST SEPSIS RESEARCH
From 6-8 September 2023 SmartDyeLivery took part in the 11th international congress on sepsis research in Weimar. With the motto „Immunotherapies – Advances and Adaptions“ the German Sepsis Society discussed the current situation of the critical care community. The meeting gave outstanding researchers the opportunity to report on the latest advances in immunomodulatory approaches to the adaptive immune response in sepsis.
SmartDyeLivery presented its innovative technology at the joint exhibitor booth with the team of InfectoGnostics Forschungscampus Jena e.V.
„The Weimar meeting has emerged as one of the most important meetings on sepsis in the world.“ – John Marshall M.D., F.R.C.S.C. (University of Toronto)
5th September 2023
SMARTDYELIVERY CONVINCES EXISTING INVESTORS TO INCREASE THEIR PARTICIPATION
In the latest round of financing, both the Foundation for Technology, Innovation and Research Thuringia (STIFT) and an existing private investor increased their holdings. The investors were motivated by the company's latest milestone - the approval of the BfArM to conduct a first clinical trial on healthy subjects. STIFT aims to promote regional science and has been supporting the innovative therapeutic concept of SmartDyeLivery since 2018.
19th July 2023
SMARTDYELIVERY GAINS SME STATUS FROM THE EUROPEAN MEDICINES AGENCY (EMA)
Our application for the registration as an SME (small and medium-sized enterprise) has been successful. Being in the SME register of the EMA entails a full or partial exemption from fees, e.g., for scientific advice or further training.
29th June 2023
LIVE AND IN COLOUR AT INNOCON
After SmartDyeLivery's last participation at InnoCON was only possible digitally, it was now even nicer to visit Thuringia's leading innovation policy event on site again. Under the slogan "More technological independence" the event dealt with the opportunities and possibilities that the new EU funding period 2021-2027 offers for Thuringian companies and researchers. SmartDyeLivery participated at InnoMARKT and informed visitors about its new BMBF-funded project "ATHANA - Antifungal therapy approaches with nanoparticle-based targeting of drugs" in a presentation.
21st June 2023
SMARTDYELIVERY RECEIVES APPROVAL FOR PHASE I CLINICAL TESTING
We've got reason to celebrate: After the examination of our clinical trial application, the Federal Institute for Drugs and Medical Devices (BfArM) has given permission to transition our first product into the clinical phase. Thus, nanocarriers that are developed for the treatment of septic liver failure can be tested on healthy subjects for the very first time.
12th June 2023
BMBF FUNDS NEW ATHANA PROJECT TO THE TUNE OF MILLIONS
The RUBIN alliance "ATHANA" is developing innovative therapeutic approaches for the treatment of infectious diseases, specifically fungal infections (Antifungal therapy approaches with nanoparticle-based targeting of drugs). SmartDyeLivery has joined forces with seven Thuringian companies and research institutions from the pharmaceutical-biotechnology and the infection and clinical research sector and acts as alliance coordinator. Together they aim to save human lives with innovative therapeutics and to develop the region into the European heart of anti-infective nanotechnologies. The Federal Ministry of Education and Research (BMBF) is funding the project with a total funding volume of almost 6 million euros over three years as part of the RUBIN program - Regional Entrepreneurial Alliances for Innovation.
8th June 2023
AFTER FOUR YEARS OF COVID BREAK: Highly-motivated members of the SmartDyeLivery team were back on the startline of the Thuringian Unternehmenslauf RUN, pounding the streets in the oldtown of Erfurt along with almost 8.600 others, completing the 5-kilometer course in style. All team members managed the run, with the odd drop of sweat shed, and enjoyed the rest of the evening on the Domplatz in Erfurt.
28th November 2022
LONG NIGHT OF SCIENCE IN JENA: Doors open for all science enthusiasts was the motto of numerous research institutions and companies in Jena on Friday from 18:00 to 24:00. SmartDyeLivery also participated again - together with the InfectoGnostics Forschungscampus Jena e.V. - and was excited about the huge crowd of young and old.
22nd November 2022
4th November 2022
MEDWAYS NETWORK MEETING IN RUDOLSTADT: On Friday afternoon, AEROPHARM opened its doors to interested medways members. In addition to a site tour of the respiratory drug producer, which belongs to Novartis, there were excellent presentations on current topics in federal politics and EU regulation for clinical research projects, among others.
26th July 2022
JOINT INTERVIEW WITH bmIt: What was so special about the start-up? What was the early phase of the company's foundation like? bmIt investment manager Stefan Jahn and managing director Dr. Marc Lehmann jointly answered these and more questions from the Thüringer Aufbaubank.
29th June 2022
ANJA TRÄGER RECEIVES ROWENA MORSE AWARD: We congratulate our co-founder Dr. Anja Träger on this award for the best young scientist at Friedrich Schiller University Jena. The prize, endowed with 5,000 €, was awarded during the Schiller Day on 24.06.2022. Rowena Morse was the first woman to receive a doctorate from the Faculty of Philosophy at the University of Jena.
15th June 2022
"SPOTLIGHT ON INNOVATION": The motto of this year's Investor Days Thuringia said it all. After two years without a presence event, the start-ups were allowed to pitch live on stage again. SmartDyelivery presented itself as a growth company during the two-day event in Erfurt's stadium.
6th April 2022
ARTICLE ON PARTICLES: Our cooperation partners at the Institute of Organic Chemistry and Macromolecular Chemistry (IOMC) at the FSU Jena have again succeeded in publishing a high-level paper on the characterization of nanoparticles. The publication on the comparison of methods for the size determination of nanoparticles has recently been accepted by the journal Analytica Chimica Acta. The scientists also used nanoparticles produced by SmartDyeLivery for this purpose. We congratulate on this success!
14th February 2022
SMARTDYELIVERY IN THE LOCAL PRESS: "We are the freight forwarder" - The article published today in the Thüringer Allgemeine describes our platform technology with vivid metaphors. The current state of research and the upcoming challenges are also brought into public focus.
26th January 2022
MILLIONS IN ADDITIONAL FINANCING SECURED: bm-t beteiligungsmanagement thüringen gmbh (bm|t) and a private investor from the existing consortium were convinced by the latest preclinical study results. With the further funding, the first study in humans will be prepared and conducted. We are happy and grateful for the continued trust!
10th September 2021
SMARTDYELIVERY AT THE "SEPSIS UPDATE" IN WEIMAR: The 10th international congress of the German Sepsis Society took place from September 8th to 10th. Under the motto "SEPSIS & COVID-19 - Beyond the Pandemic", the challenges of the pandemic in intensive care medicine were discussed. The pandemic also shaped the event itself: Planned as a hybrid event, the number of participants was limited on site and many lectures were connected online.
SmartDyeLivery was present as an exhibitor and presented its innovative technology at the joint stand with the InfectoGnostics Forschungscampus Jena e.V.
26th March 2021
PROJECT CONVINCED AND FUNDED IN THE FRAMEWORK OF A ZIM COOPERATION BY BMWI: The Federal Ministry for Economic Affairs and Energy (BMWi) is funding a joint project of the Institute of Organic and Macromolecular Chemistry (IOMC) of Friedrich Schiller University Jena, Prof. Dr. Michael Gottschaldt, the Clinic for Nuclear Medicine and its chief physician Prof. Dr. med. Martin Freesmeyer, and SmartDyeLivery GmbH. The project aims to develop a novel, nanostructured theranostic for applications in oncology.
19th March 2021
»OPERATION AIR CASTLE« AIR CLEANERS FOR JENA SCHOOLS AND KINDERGARTENS: As part of the Nanotechnology Foundation's »Operation Air Castle« initiative, SmartDyeLivery GmbH has also provided one of 17 air cleaners for schools and kindergardens in Jena, along with other Jena-based companies, private individuals and initiatives. The devices are intended to stop or reduce the spread of the SARS-CoV-2 viruses and thus enable safer teaching or care. The detailed press release can be found here.
Image (f.l.): Dr. Marc Lehmann (CEO SmartDyeLivery GmbH), Dennis Sippach (Geschäftsführer IVOC-X GmbH), Prof. Dr. Ulrich S. Schubert (Stiftung Nanotechnologie)
Photo: © Sylvia Braunsdorf
29th January 2021
POLYTARGET PRESENT THEIR NEW IMAGE FILM: Within the framework of the Collaborative Research Center »PolyTarget« of the Deutschen Forschungsgemeinschaft, the co-founders of SmartDyeLivery GmbH (Prof. Dr Ulrich S. Schubert, Prof. Dr med. Michael Bauer and Dr Anja Träger) are developing innovative pharmaceutical polymers and nanoparticles for use in nanomedicine. The image film shows the research work in which the SmartDyeLivery GmbH is a strategic partner.
7th December 2020
JOINT PUBLICATION WITH RESEARCHERS OF THE UNIVERSITY OF JENA AWARDED: The high-ranking publication in the scientific journal Nanoscale, published jointly with scientists from the Institute of Organic Chemistry and Macromolecular Chemistry (IOMC) on October 8, 2020, has been added to the Topic Collection 2020 Nanoscale HOT Article Collection.
4th December 2020
SMARTDYELIVERY GMBH PRESENTS ITSELF AT INNOCON: This year's InnoCON took place on November 24th as a digital event under the motto »On the way to innovative value-added networks«. SmartDyeLivery presented itself together with numerous Thuringian stakeholders and networks at the big InnoPITCH.
14th October 2020
SUCCESSFUL MULTI-MILLION FINANCING ROUND: SmartDyeLivery is pleased to announce the successful completion of its most recent financing round. In addition to bm-t beteiligungsmanagement thüringen gmbh (bm|t), which increased its lead investment, the Stiftung für Technologie, Innovation und Forschung Thüringen (STIFT), a group of business angels was also convinced. The investment will be used to finance important development steps for the specific therapy of septic liver failure - up to the first application in humans.
8th October 2020
JOINT PUBLICATION WITH RESEARCHERS FROM THE UNIVERSITY OF JENA: The close cooperation with scientists from the Institute of Organic Chemistry and Macromolecular Chemistry (IOMC), work continued on the jointly developed method for the quantitative investigation of physicochemical properties of nanoparticles, including in human blood serum. The experimentally developed methods will in future allow comprehensive quality assurance in nanomedical applications. The results were published in a joint high-ranking publication in the scientific journal Nanoscale.
29th September 2020
JOINT PUBLICATION WITH BETEILIGUNGSMANAGEMENT THÜRINGEN GMBH (bm|t): The article »Gezielter Wirkstofftransport – eine Herausforderung« by SmartDyeLivery GmbH and bm-t beteiligungsmanagement thüringen GmbH was published in the e-magazine Plattform Life Sciences - 3/2020 »Biotechnology«. The approach of »packaging« active pharmaceutical ingredients in nanotransporters is expected to play an increasing role in personalized medicine in the future.
16th June 2020
INVESTOR DAYS THURINGIA - DIGITAL EDITION FROM 16-17 JUNE: This year everything is different and so Thuringia Investor Days will be presented in a new digital format. Under the theme "Playing Changes", innovative start-ups and growth companies can present themselves to potential investors and business angels from home in live pitches and with a virtual exhibition booth. SmartDyeLivery will also be part of the event again and is looking forward to two exciting virtual days!
19th May 2020
JOINT PUBLICATION WITH RESEARCHERS FROM THE UNIVERSITY OF JENA: The close cooperation with scientists from the Institute of Organic Chemistry and Macromolecular Chemistry (IOMC) has now resulted in a shared high-ranking publication in the journal Analytical Chemistry. In this paper, young scientist Gizem Cinar and colleagues present a new method for the quantitative investigation of physicochemical properties of nanoparticles, among other things, in human blood serum. The experimentally developed methods can be used for future comprehensive quality assurance in nanomedical applications.
6th May 2020
THE THURINGIAN PHARMA COMMUNITY IS ONLINE! With its joint Internet presence, the Thuringian Pharma Community is now showing the unique close cooperation between science, industry and medicine to the outside world.
Founded in 2016, the initiative has set itself the goal of giving Thuringia a lasting and unmistakable visibility as a pharmaceutical location. The community now comprises 20 partners, including companies of all sizes, research institutes, hospitals and state institutions. SmartDyeLivery has also joined the community in 2019 and has already been able to win valuable cooperation.
Take a look at: www.thueringer-pharma-community.de
27th April 2020
POLYMER CHEMISTRY - RESEARCH AT THE HIGHEST LEVEL: SmartDyeLivery co-founder Prof. Dr. Ulrich S. Schubert ranks highly in the list of the world's most influential scientists of all time. The list includes both living and deceased authors who have an h-index of >100 and are therefore considered highly cited researchers. The h-Index (Hirsch-Index) is named after the physicist Jorge E. Hirsch, and is an indicator of the worldwide reputation of a scientist in professional circles.
12th February 2020
BIOTECH FINANCE SUMMIT 2020: On February 11, BIO Deutschland, the trade association of the biotechnology industry, invited to this year's CFO Summit in Berlin. The participants were able to gather information and exchange views on all aspects of finance. Dr. Marc Lehmann, CEO of SmartDyeLivery, was also attending and confirmed an exciting program with many opportunities for discussion and networking.
18th November 2019
SMARTDYELIVERY AT THE LONG NIGHT OF SCIENCE: On Friday, November 22, the Long Night of Science takes place from 6 to 12 pm in Jena. We are prepared: If you want to learn more about "smart" nanocarriers, visit us at the Center for Applied Research, Philosophenweg 7. At our booth you can create "smart particles" yourself and playfully bring particles into the liver!
31th October 2019
PRIZE FOR YOUNG SCIENTIST: Congratulations to our co-founder, Dr. Anja Träger, for receiving a Young Scientist Award from the Macromolecular Chemistry Section of the German Chemical Society (Gesellschaft Deutscher Chemiker e.V.). (GDCh)! Dr. Träger leads a working group at the Jena Center for Soft Matter (JCSM) of the University of Jena and has supported SmartDyeLivery since the beginning with her expertise in the field of complex polymer nanostructures.
16th September 2019
SMARTDYELIVERY AT THE CONGRESS OF THE GERMAN SEPSIS-SOCIETY: Sepsis experts from all over the world discussed current developments in intensive care medicine at the Sepsis Update, which took place last week in Weimar. Our co-founder Prof. Michael Bauer, Director of the Clinic for Anaesthesiology and Intensive Care at the University Hospital of Jena and spokesman for the Center for Sepsis Control & Care (CSCC), reported on the current therapy and future medical requirements for septic liver failure. The SmartDyeLivery team heard the latest findings from sepsis research.
3rd September 2019
MEET US AT SEPSIS UPDATE CONGRESS IN WEIMAR: At the 9th International Congress "Sepsis & Multiorgan Failure" in Weimar from September 11th to 13th, SmartDyeLivery will again present itself together with the InfectoGnostics research campus. Come and see us! We are looking forward to stimulating discussions and an intensive exchange.
15th July 2019
INNOVATIVE POLYMERS FOR THE NANOMEDICINE OF THE 21st CENTURY: The Collaborative Research Center PolyTarget of the Friedrich Schiller University Jena is organizing a three-day symposium on this topic in-house. In front of an international audience, top-class experts will speak about current and future developments in the medicinal application of nanomaterials. SmartDyeLivery supports the event and looks forward to an excellent scientific exchange.
27th June 2019
INDUSTRY CONTACT FORUM AM LEIBNIZ-HKI: For the second time, the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI) organized an Industry Contact Forum for the exchange of doctoral students and industrial partners. SmartDyeLivery introduced itself with a company presentation and answered questions about career opportunities and everyday working life.
6th June 2019
AT THE START OF THE THURINGIAN CORPORATE CHALLENGE 2019:
The SmartDyeLivery team took part in the RUN in Erfurt again this year. With temperatures above 30°C we sweated yesterday evening together with 9300 other runners on the almost 5 km long track. It was again a top organized event!
22nd May 2019
SMARTDYELIVERY AT THURINGIAN PHARMA COMMUNITY'S SPRING YEAR MEETING: Gera-based HAPILA GmbH hosted representatives of Thuringian pharmaceutical companies, academic research institutions and clinical study centres at the beginning of May. The Thuringian Pharma Community, which was founded in 2016 and has grown considerably since then, offers the Thuringian pharmaceutical industry a common platform. The aim is to bring together the entire value creation chain - from drug development to clinical trials and marketing - in Thuringia and make better use of existing potential. In the future, a joint public presence, including a website, will further strengthen the exchange.
12th April 2019
RESEARCH CAMPUS EXPERTS VISITED SMARTDYELIVERY: SmartDyeLivery opened its doors yesterday as part of a guided tour of the InfectoGnostics research campus. InfectoGnostics is one of nine research campuses funded as public-private partnerships by the German Federal Ministry of Education and Research (BMBF). Approximately 40 representatives of all research camps plus representatives of the BMBF and the project executing agency Jülich travelled to Jena for a two-day workshop on the topic of "digitization". As an official partner, SmartDyeLivery also presented its work to the interested audience.
17th January 2019
WOULD YOU LIKE TO TAKE ON NEW TASKS? We continue to grow and are looking for motivated employees to strengthen our team. We are looking forward to your application! Click here for the job advertisements
4th January 2019
THURINGIA SUPPORTS NEW RESEARCH PROJECT: The Thüringer Aufbaubank is also supporting our latest project in the field of developing nanotherapeutics for biomedical use. We are grateful about the financial support and are starting with a great research spirit into new year!